MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Pallidal DBS and pallidotomy alter cortical synchronization in Parkinson’s disease

    S. Miocinovic, C. De Hemptinne, A. Miller, J.L. Ostrem, P.A. Starr (San Francisco, CA, USA)

    Objective: To investigate electrophysiologic characteristics of sensorimotor cortical activity in patients with Parkinson's disease (PD) undergoing globus pallidus deep brain stimulation (GPi DBS) or radiofrequency…
  • 2016 International Congress

    Recruitment of single subthalamic neurons for kinematic control of hand and feet movements employs different strategies

    A. Tankus, A. Mirelman, N. Giladi, I. Fried, J.M. Hausdorff (Tel-Aviv, Israel)

    Objective: To understand single unit recruitment strategies for upper and lower extremity movements in the human subthalamic nucleus (STN), which is the main target for…
  • 2016 International Congress

    Effectiveness of Levodopa responsiveness of Blink reflex recovery: An objective method to differentiate Parkinsonian syndromes

    C. Gaddipati, M. Umaiorubahan, C.U. Velmurugendran, V. Shankar (Chennai, India)

    Objective: We attempted to find an objective tool by assessing the variability of levodopa induced change in the blink reflex recovery to differentiate Parkinsonian syndromes.…
  • 2016 International Congress

    Increasing placebo response in Parkinson’s disease through apomorphine pre-conditioning

    E. Frisaldi, E. Carlino, L. Giudetti, A. Pampallona, M. Zibetti, M. Lanotte, L. Lopiano, F. Benedetti (Turin, Italy)

    Objective: To see whether a placebo response requires pharmacological pre-conditioning with apomorphine. Background: Placebos have been found to affect the patient's brain in a number…
  • 2016 International Congress

    Diffusion tensor imaging of the corticospinal tract differentiates Parkinson’s disease (PD) patients from controls

    R. Guimaraes, B. Campos, L. Campos, L. Piovesana, P. Azevedo, A. D'Abreu, F. Cendes (Campinas, Brazil)

    Objective: To asses white matter tractography of the corticospinal tract in PD patients. Background: Since the diagnosis of PD is still based on clinical assessment,…
  • 2016 International Congress

    Diagnostic reliability of clinical symptoms in patients with incomplete manifestation of the triad of parkinsonism compared to 18F-DOPA PET-CT MRI imaging

    C. Peralta, T. Soto Depetris, A. Perez, F. Biafore, J. Gili, A. Valda, D. Menna, M. Aguilar, H. Corradini, M. Bastianello (Caba, Argentina)

    Objective: To describe the diagnostic reliability of the triad of clinical symptoms compared to the uptake of 18 F-DOPA PET-CT fusion MRI scan. To compare…
  • 2016 International Congress

    Brain mechanisms underlying visual processing in Parkinson’s disease

    I. Rektorova, N. Elfmarkova, M. Gajdos, R. Marecek, S. Rapcsak (Brno, Czech Republic)

    Objective: We used fMRI and a visual cognitive task to study brain mechanisms underlying visual processing at different cognitive loads in patients with PD and…
  • 2016 International Congress

    Cerebellar GABA-A receptor activity is inversely correlated with gait speed in Parkinson’s disease

    N.I. Bohnen, K.A. Frey, R.A. Koeppe, P.J.H. Scott, M.L.T.M. Muller (Ann Arbor, MI, USA)

    Objective: To investigate the relationship between regional cerebral expression of benzodiazepine receptors and gait speed in Parkinson's disease (PD). Background: Flumazenil is a short-acting intravenously…
  • 2016 International Congress

    Combined effects of visual and auditory cues on gait initiation in Parkinson’s disease

    T. Hashimoto, H. Sato (Matsumoto, Japan)

    Objective: To investigate the combined effects of visual and auditory cues on gait initiation and to investigate the correlation between the clinical rates of gait…
  • 2016 International Congress

    Comparison of DAT scan, cardiac MIBG scintigraphy, and cerebrospinal fluid 5HIAA levels in Parkinsonian syndrome

    R. Sengoku, M. Yamazaki, D. Kaneda, Y. Nishina, A.M. Tokumaru, S. Murayama (Tokyo, Japan)

    Objective: To assess the associations of presynaptic dopamine transporter (DAT scan), cardiac 123I-meta-iodobenzylguanidine (MIBG) scintigraphy, and cerebrospinal fluid (CSF) levels of 5-hydroxyindole acetic acid (5HIAA)…
  • « Previous Page
  • 1
  • …
  • 1857
  • 1858
  • 1859
  • 1860
  • 1861
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley